Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

This study has been terminated.
(Slow accrual due to restrictive eligibility criteria)
Sponsor:
Collaborator:
Brigham and Women's Hospital
Information provided by (Responsible Party):
Raymond H. Mak, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01222572
First received: October 8, 2010
Last updated: October 21, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)